-
Notifications
You must be signed in to change notification settings - Fork 0
Expand file tree
/
Copy pathindex.html
More file actions
339 lines (331 loc) · 26.6 KB
/
Copy pathindex.html
File metadata and controls
339 lines (331 loc) · 26.6 KB
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
242
243
244
245
246
247
248
249
250
251
252
253
254
255
256
257
258
259
260
261
262
263
264
265
266
267
268
269
270
271
272
273
274
275
276
277
278
279
280
281
282
283
284
285
286
287
288
289
290
291
292
293
294
295
296
297
298
299
300
301
302
303
304
305
306
307
308
309
310
311
312
313
314
315
316
317
318
319
320
321
322
323
324
325
326
327
328
329
330
331
332
333
334
335
336
337
338
339
<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="UTF-8" />
<meta name="viewport" content="width=device-width, initial-scale=1.0" />
<title>NeuroLens — A High School Student's Journey into Neuroscience</title>
<meta name="description" content="A South Korean student at Mercersburg Academy documents his journey into neurotechnology, brain research, and the quest to understand Parkinson's disease and Alzheimer's. Class of 2028." />
<meta name="keywords" content="neuroscience, neurotechnology, Parkinson's disease, Alzheimer's disease, Meta glasses, brain mapping, CRISPR, biotech, high school research, neurotech blog" />
<meta name="author" content="NeuroLens" />
<meta property="og:title" content="NeuroLens — A High School Student's Journey into Neuroscience" />
<meta property="og:description" content="Documenting a personal mission to understand and one day help cure Parkinson's and Alzheimer's disease — through neurotechnology, biotech, and relentless curiosity." />
<meta property="og:type" content="website" />
<link rel="canonical" href="https://yourusername.github.io/neurolens/" />
<link rel="preconnect" href="https://fonts.googleapis.com" />
<link rel="preconnect" href="https://fonts.gstatic.com" crossorigin />
<link href="https://fonts.googleapis.com/css2?family=Inter:wght@400;500&family=Lora:ital,wght@0,400;0,500;1,400&display=swap" rel="stylesheet" />
<style>
*, *::before, *::after { box-sizing: border-box; margin: 0; padding: 0; }
:root {
--teal: #1D9E75; --teal-light: #E1F5EE; --teal-mid: #0F6E56;
--text-primary: #111110; --text-secondary: #5F5E5A; --text-tertiary: #888780;
--border: rgba(0,0,0,0.1); --bg: #ffffff; --bg-secondary: #F7F6F3; --max: 740px;
}
html { scroll-behavior: smooth; }
body { font-family: 'Inter', sans-serif; color: var(--text-primary); background: var(--bg); -webkit-font-smoothing: antialiased; }
nav {
position: sticky; top: 0; z-index: 100;
background: rgba(255,255,255,0.93); backdrop-filter: blur(12px);
border-bottom: 0.5px solid var(--border);
padding: 0 40px; display: flex; align-items: center; justify-content: space-between; height: 58px;
}
.nav-logo { font-size: 15px; font-weight: 500; text-decoration: none; color: var(--text-primary); }
.nav-logo span { color: var(--teal); }
.nav-links { display: flex; gap: 28px; list-style: none; }
.nav-links a { font-size: 13px; color: var(--text-secondary); text-decoration: none; transition: color 0.15s; }
.nav-links a:hover, .nav-links a.active { color: var(--text-primary); }
.container { max-width: var(--max); margin: 0 auto; padding: 0 40px; }
section { padding: 80px 0; border-bottom: 0.5px solid var(--border); }
.hero { padding: 100px 0 88px; }
.hero-tag {
display: inline-block; font-size: 11px; font-weight: 500; letter-spacing: 0.08em;
text-transform: uppercase; color: var(--teal-mid); background: var(--teal-light);
padding: 4px 12px; border-radius: 20px; margin-bottom: 26px;
}
.hero h1 {
font-family: 'Lora', serif; font-size: clamp(32px, 5vw, 48px);
font-weight: 500; line-height: 1.18; margin-bottom: 24px; max-width: 600px;
}
.hero h1 em { font-style: italic; color: var(--teal); }
.hero-lead { font-size: 17px; line-height: 1.85; color: var(--text-secondary); max-width: 580px; margin-bottom: 38px; }
.btn-group { display: flex; gap: 12px; flex-wrap: wrap; }
.btn-primary {
display: inline-flex; align-items: center; gap: 8px;
background: var(--teal); color: #fff; font-family: 'Inter', sans-serif;
font-size: 14px; font-weight: 500; padding: 11px 22px; border-radius: 8px;
text-decoration: none; transition: opacity 0.15s;
}
.btn-primary:hover { opacity: 0.86; }
.btn-ghost {
display: inline-flex; align-items: center; gap: 6px;
background: transparent; color: var(--text-secondary); font-family: 'Inter', sans-serif;
font-size: 14px; padding: 11px 0; text-decoration: none; transition: color 0.15s;
}
.btn-ghost:hover { color: var(--text-primary); }
.eyebrow { font-size: 11px; font-weight: 500; letter-spacing: 0.08em; text-transform: uppercase; color: var(--text-tertiary); margin-bottom: 8px; }
.sec-title { font-family: 'Lora', serif; font-size: clamp(22px, 3vw, 30px); font-weight: 500; margin-bottom: 12px; line-height: 1.28; }
.sec-sub { font-size: 15px; color: var(--text-secondary); max-width: 540px; margin-bottom: 42px; line-height: 1.75; }
.story-body { font-size: 16px; line-height: 1.95; color: var(--text-secondary); margin-bottom: 22px; max-width: 640px; }
.pullquote { border-left: 2px solid var(--teal); padding: 6px 0 6px 24px; margin: 36px 0; }
.pullquote p { font-family: 'Lora', serif; font-size: 19px; line-height: 1.72; color: var(--text-primary); font-style: italic; max-width: 580px; }
.two-col { display: grid; grid-template-columns: 1fr 1fr; gap: 48px; align-items: start; }
.stats-grid { display: grid; grid-template-columns: 1fr 1fr; gap: 14px; margin-top: 32px; }
.stat-card { background: var(--bg-secondary); border-radius: 10px; padding: 20px 22px; }
.stat-num { font-family: 'Lora', serif; font-size: 34px; font-weight: 500; color: var(--teal); line-height: 1; margin-bottom: 6px; }
.stat-label { font-size: 13px; color: var(--text-secondary); line-height: 1.55; }
.topics-grid { display: grid; grid-template-columns: repeat(auto-fit, minmax(210px, 1fr)); gap: 14px; }
.topic-card {
background: var(--bg); border: 0.5px solid var(--border);
border-radius: 12px; padding: 24px 20px;
transition: border-color 0.15s, transform 0.15s; text-decoration: none; color: inherit; display: block;
}
.topic-card:hover { border-color: rgba(0,0,0,0.22); transform: translateY(-2px); }
.topic-tag {
display: inline-block; font-size: 10px; font-weight: 500;
letter-spacing: 0.06em; text-transform: uppercase;
padding: 2px 9px; border-radius: 20px; margin-bottom: 13px;
}
.tag-tech { background: #E1F5EE; color: #0F6E56; }
.tag-neuro { background: #E6F1FB; color: #185FA5; }
.tag-personal { background: #FAEEDA; color: #854F0B; }
.tag-biotech { background: #EEEDFE; color: #534AB7; }
.topic-name { font-size: 14px; font-weight: 500; margin-bottom: 8px; }
.topic-body { font-size: 13px; color: var(--text-secondary); line-height: 1.75; }
.blog-list { display: flex; flex-direction: column; }
.blog-item {
display: flex; align-items: flex-start; gap: 20px;
padding: 26px 0; border-bottom: 0.5px solid var(--border);
text-decoration: none; color: inherit; transition: opacity 0.15s;
}
.blog-item:last-child { border-bottom: none; }
.blog-item:hover { opacity: 0.68; }
.blog-num { font-size: 11px; font-weight: 500; color: var(--text-tertiary); min-width: 24px; padding-top: 4px; }
.blog-body { flex: 1; }
.blog-tag {
display: inline-block; font-size: 10px; font-weight: 500;
letter-spacing: 0.06em; text-transform: uppercase;
padding: 2px 9px; border-radius: 20px; margin-bottom: 7px;
}
.blog-title { font-size: 15px; font-weight: 500; margin-bottom: 6px; }
.blog-desc { font-size: 13px; color: var(--text-secondary); line-height: 1.7; }
.blog-meta { font-size: 11px; color: var(--text-tertiary); margin-top: 8px; }
.blog-arrow { color: var(--text-tertiary); padding-top: 4px; font-size: 16px; }
.about-grid { display: grid; grid-template-columns: 1fr 1fr; gap: 12px; margin-top: 36px; }
.about-card { background: var(--bg-secondary); border-radius: 10px; padding: 18px 20px; }
.about-card-label { font-size: 11px; font-weight: 500; letter-spacing: 0.06em; text-transform: uppercase; color: var(--text-tertiary); margin-bottom: 7px; }
.about-card-val { font-size: 13px; color: var(--text-secondary); line-height: 1.65; }
.mission-strip {
background: var(--bg-secondary); border-radius: 16px;
padding: 48px 44px; margin: 0;
}
.disease-cards { display: grid; grid-template-columns: 1fr 1fr; gap: 16px; margin-top: 32px; }
.disease-card { background: var(--bg); border: 0.5px solid var(--border); border-radius: 12px; padding: 24px 22px; }
.disease-card-title { font-size: 15px; font-weight: 500; margin-bottom: 6px; color: var(--text-primary); }
.disease-card-sub { font-size: 12px; color: var(--teal); font-weight: 500; margin-bottom: 10px; }
.disease-card-body { font-size: 13px; color: var(--text-secondary); line-height: 1.75; }
footer { padding: 36px 0; display: flex; align-items: center; justify-content: space-between; flex-wrap: wrap; gap: 12px; }
.footer-name { font-size: 13px; color: var(--text-tertiary); }
.footer-links { display: flex; gap: 22px; }
.footer-links a { font-size: 13px; color: var(--text-tertiary); text-decoration: none; transition: color 0.15s; }
.footer-links a:hover { color: var(--text-primary); }
@media (max-width: 640px) {
nav { padding: 0 20px; } .nav-links { gap: 16px; }
.container { padding: 0 20px; } section { padding: 56px 0; }
.hero { padding: 68px 0 56px; } .two-col { grid-template-columns: 1fr; gap: 28px; }
.stats-grid, .about-grid, .disease-cards { grid-template-columns: 1fr; }
}
</style>
</head>
<body>
<nav>
<a class="nav-logo" href="index.html">Neuro<span>Lens</span></a>
<ul class="nav-links">
<li><a href="#story">My Story</a></li>
<li><a href="#topics">Topics</a></li>
<li><a href="journal.html">Journal</a></li>
<li><a href="#about">About</a></li>
</ul>
</nav>
<!-- HERO -->
<section class="hero" id="home">
<div class="container">
<div class="hero-tag">Class of 2028 · Mercersburg Academy · Aspiring Neuroscientist</div>
<h1>I'm not a scientist yet.<br>But I already know <em>why</em> I want to become one.</h1>
<p class="hero-lead">Both of my grandfathers are losing themselves to brain disease — one to Parkinson's, one to Alzheimer's. Modern medicine has treatments. It doesn't have cures. That felt unacceptable to me. So I started reading, researching, and building. This is where I document everything.</p>
<div class="btn-group">
<a href="#story" class="btn-primary">Read my story →</a>
<a href="journal.html" class="btn-ghost">Explore the journal →</a>
</div>
</div>
</section>
<!-- STORY -->
<section id="story">
<div class="container">
<div class="eyebrow">Where this all began</div>
<h2 class="sec-title">Two grandfathers. Two diseases.<br>One reason to keep going.</h2>
<p class="story-body">I grew up between two worlds. In South Korea, surrounded by family. At Mercersburg Academy in Pennsylvania, learning to think independently and rigorously. But no matter where I am, I carry the same weight: both of my grandfathers are being taken apart by diseases that science still cannot reverse.</p>
<p class="story-body">My maternal grandfather has Parkinson's disease. He was one of the most present people I've ever known — warm, deliberate, always there. I watched his hands start to tremble. I watched him lose the steadiness that I associated with him so completely that it felt like losing part of who he was. The doctors gave him medication. They talked about managing symptoms. No one talked about a cure, because there isn't one.</p>
<p class="story-body">My paternal grandfather has Alzheimer's disease. With him, the loss has been different — slower in some ways, more disorienting. He forgets things. Then he forgets people. There are days he looks at me and I can see him searching — reaching for something that used to be automatic. Both of them treated me like I was the most important person in any room. They gave me memories I will carry my whole life. They deserve better than what medicine currently offers them.</p>
<div class="pullquote">
<p>Losing someone to memory loss isn't like losing them all at once. It's hundreds of small losses — a name, a story, a moment of recognition. And each one reminds you how much still needs to be discovered.</p>
</div>
<p class="story-body">I didn't set out to become interested in neuroscience. I became interested in it the way you become interested in anything that feels urgent — because the alternative was just watching, and I couldn't do that. So I read. I found papers on dopamine and alpha-synuclein aggregation. I learned what plaques and tangles actually are and why they kill neurons. I read about deep brain stimulation for Parkinson's and about anti-amyloid antibodies for Alzheimer's. I stayed up past 2 a.m. reading about clinical trials. I wasn't looking for comfort. I was looking for a way in.</p>
<p class="story-body">That's when neurotechnology entered the picture. Brain-computer interfaces. Augmented reality as a diagnostic tool. Biosensors that detect neurological change before symptoms appear. Meta glasses that might one day map how perception breaks down in disease. I realized that the future of neuroscience wasn't just biology — it was the intersection of biology and technology. And that's the intersection I want to live and work in.</p>
<p class="story-body">This website is where I document that journey. Every concept I learn, every paper I wrestle with, every question I can't yet answer — it goes here. I'm a junior in high school. I don't have the answers. But I'm building the foundation to find them.</p>
<div class="stats-grid">
<div class="stat-card"><div class="stat-num">55M+</div><div class="stat-label">People living with dementia worldwide — a number expected to triple by 2050</div></div>
<div class="stat-card"><div class="stat-num">10M+</div><div class="stat-label">People living with Parkinson's disease globally, with no cure in sight</div></div>
<div class="stat-card"><div class="stat-num">0</div><div class="stat-label">Diseases that fully reverse Alzheimer's or Parkinson's progression — as of today</div></div>
<div class="stat-card"><div class="stat-num">$3B+</div><div class="stat-label">Invested annually in neurodegenerative disease research — progress is happening, but slowly</div></div>
</div>
</div>
</section>
<!-- DISEASES DEEP DIVE -->
<section id="diseases">
<div class="container">
<div class="eyebrow">The diseases I'm studying</div>
<h2 class="sec-title">Understanding what I'm up against</h2>
<p class="sec-sub">Before you can help solve a problem, you have to understand it. Here's what I've learned so far about the two diseases shaping my life and my research direction.</p>
<div class="disease-cards">
<div class="disease-card">
<div class="disease-card-title">Parkinson's Disease</div>
<div class="disease-card-sub">My maternal grandfather's diagnosis</div>
<div class="disease-card-body">Parkinson's is caused by the loss of dopamine-producing neurons in a brain region called the substantia nigra. Without enough dopamine, movement becomes difficult to control. The hallmarks — tremors, rigidity, slowness — are just the visible surface. Beneath them is a process of protein misfolding: clumps of alpha-synuclein called Lewy bodies accumulate and kill neurons. Current treatments manage symptoms but don't stop the underlying damage. Deep brain stimulation, the most advanced intervention available, sends electrical pulses into the subthalamic nucleus to reduce tremors — but it doesn't touch the cause.</div>
</div>
<div class="disease-card">
<div class="disease-card-title">Alzheimer's Disease</div>
<div class="disease-card-sub">My paternal grandfather's diagnosis</div>
<div class="disease-card-body">Alzheimer's is the most common form of dementia, responsible for 60–70% of cases. It's defined by two pathological features: amyloid-beta plaques that accumulate between neurons, and tau tangles that form inside them. Together, they disrupt and eventually destroy neural communication. Memory goes first because the hippocampus — the brain's memory center — is hit earliest. There are now FDA-approved anti-amyloid antibodies like lecanemab that can slow progression in early stages, but they don't reverse damage. The window for intervention, if there is one, is before symptoms begin — which is why early detection through biomarkers and imaging is one of the most important frontiers in the field right now.</div>
</div>
</div>
</div>
</section>
<!-- TOPICS -->
<section id="topics">
<div class="container">
<div class="eyebrow">What I care about</div>
<h2 class="sec-title">My research interests</h2>
<p class="sec-sub">Four areas at the intersection of neuroscience and technology — the ones I keep returning to, the ones I think matter most.</p>
<div class="topics-grid">
<a href="journal.html#ar" class="topic-card">
<span class="topic-tag tag-tech">Tech</span>
<div class="topic-name">Meta Glasses & AR</div>
<div class="topic-body">Most people see Meta glasses as a consumer product. I see them as a potential research tool — a way to study perception in real environments, track subtle behavioral changes that signal early disease, and eventually build assistive overlays for patients with cognitive decline. The brain constructs reality from sensory input. AR disrupts that process in controlled ways. That makes it scientifically interesting.</div>
</a>
<a href="journal.html#mapping" class="topic-card">
<span class="topic-tag tag-neuro">Neuroscience</span>
<div class="topic-name">Brain Mapping</div>
<div class="topic-body">The human brain has 86 billion neurons and roughly 100 trillion synaptic connections. We've mapped less of it than we've mapped the ocean floor. New tools — ultra-high-field fMRI, calcium imaging, single-cell sequencing — are beginning to change that. I'm particularly interested in the circuits involved in memory formation and motor control: the exact systems disrupted by Alzheimer's and Parkinson's.</div>
</a>
<a href="journal.html#pd-ad" class="topic-card">
<span class="topic-tag tag-personal">Personal</span>
<div class="topic-name">Parkinson's & Alzheimer's</div>
<div class="topic-body">This is the one that started everything. Two grandfathers, two diagnoses, zero cures. I study these diseases not just to understand them academically but because understanding them is the first step toward doing something about them. Every paper I read on alpha-synuclein, every article on amyloid clearance, every clinical trial result — it all goes toward the same goal.</div>
</a>
<a href="journal.html#biotech" class="topic-card">
<span class="topic-tag tag-biotech">Biotech</span>
<div class="topic-name">Biotech Frontiers</div>
<div class="topic-body">CRISPR can now edit a single nucleotide with near-surgical precision. Viral vectors can ferry therapeutic genes directly into neurons. Wearable biosensors can detect neurological changes months before clinical symptoms appear. These tools are being used in labs and clinical trials right now. The most important breakthroughs in brain disease will come from people who understand both the biology and the engineering.</div>
</a>
</div>
</div>
</section>
<!-- MISSION -->
<section id="mission" style="border-bottom:0.5px solid var(--border); padding: 0;">
<div class="container" style="padding-top:0; padding-bottom:0;">
<div class="mission-strip">
<div class="eyebrow">My mission</div>
<h2 class="sec-title" style="max-width:520px;">The most important frontier isn't outer space. It's inside our skulls.</h2>
<p class="story-body" style="margin-bottom:18px;">We send satellites to map distant planets. We build particle accelerators to study the smallest units of matter. And yet the three-pound organ that does the observing — the one that holds every memory, every personality, every dream — remains largely unmapped and poorly understood.</p>
<p class="story-body" style="margin-bottom:18px;">I believe the next great era of discovery is neurological. I believe the tools being built now — brain-computer interfaces, AR overlays, single-cell sequencing, gene therapies — will do for brain disease what antibiotics did for infection. And I believe that the people who will make that happen are in high school right now, learning how to ask the right questions.</p>
<p class="story-body" style="margin-bottom:0;">I'm one of them. And I'm getting started.</p>
</div>
</div>
</section>
<!-- JOURNAL PREVIEW -->
<section id="journal-preview">
<div class="container">
<div class="eyebrow">Research journal</div>
<h2 class="sec-title">Latest entries</h2>
<p class="sec-sub">My ongoing record of what I'm reading, learning, and thinking about — in public, from the beginning.</p>
<div class="blog-list">
<a href="journal.html#dbs" class="blog-item">
<div class="blog-num">01</div>
<div class="blog-body">
<span class="blog-tag tag-neuro">Neuroscience</span>
<div class="blog-title">Deep brain stimulation — shocking the brain back to life</div>
<div class="blog-desc">Surgeons implant electrodes deep in the brain and send electrical pulses into the subthalamic nucleus. For many Parkinson's patients, tremors stop almost immediately. I wanted to understand exactly how — and why it still doesn't count as a cure.</div>
<div class="blog-meta">Entry 01 · Parkinson's Disease</div>
</div>
<div class="blog-arrow">→</div>
</a>
<a href="journal.html#amyloid" class="blog-item">
<div class="blog-num">02</div>
<div class="blog-body">
<span class="blog-tag tag-biotech">Biotech</span>
<div class="blog-title">Lecanemab and the hope of slowing Alzheimer's</div>
<div class="blog-desc">In 2023, the FDA approved lecanemab — an antibody that clears amyloid plaques from the brain. It's the most significant Alzheimer's drug in decades. I read the trial data and tried to understand what "slowing progression by 27%" actually means for a patient.</div>
<div class="blog-meta">Entry 02 · Alzheimer's Disease</div>
</div>
<div class="blog-arrow">→</div>
</a>
<a href="journal.html#ar" class="blog-item">
<div class="blog-num">03</div>
<div class="blog-body">
<span class="blog-tag tag-tech">Tech</span>
<div class="blog-title">What Meta glasses taught me about how the brain builds reality</div>
<div class="blog-desc">AR forces the brain to integrate real and digital information simultaneously. The way it handles — or fails to handle — that integration reveals how visual processing actually works. And it opened my mind to what these devices could do in a clinical setting.</div>
<div class="blog-meta">Entry 03 · Neurotechnology</div>
</div>
<div class="blog-arrow">→</div>
</a>
<a href="journal.html#crispr" class="blog-item">
<div class="blog-num">04</div>
<div class="blog-body">
<span class="blog-tag tag-biotech">Biotech</span>
<div class="blog-title">Could CRISPR edit away Parkinson's?</div>
<div class="blog-desc">Some Parkinson's cases are linked to mutations in LRRK2 and PINK1. If CRISPR can correct a single DNA letter, could it fix these mutations before neurodegeneration begins? I read the early research — and found both real promise and honest obstacles.</div>
<div class="blog-meta">Entry 04 · Gene Therapy</div>
</div>
<div class="blog-arrow">→</div>
</a>
</div>
<div style="margin-top: 32px;">
<a href="journal.html" class="btn-primary">View all journal entries →</a>
</div>
</div>
</section>
<!-- ABOUT -->
<section id="about">
<div class="container">
<div class="eyebrow">About</div>
<h2 class="sec-title">Who I am</h2>
<p class="story-body">I'm a South Korean student at Mercersburg Academy in Pennsylvania, rising junior, Class of 2028. I came to the United States as a boarding student, which means I live between two cultures — carrying the warmth of Korean family traditions and the rigorous academic environment of an American prep school.</p>
<p class="story-body">My interest in neuroscience didn't come from a class. It came from my family. My maternal grandfather was diagnosed with Parkinson's disease, my paternal grandfather with Alzheimer's. Two of the most important men in my life, each losing something essential to brain disease. They were the kind of grandfathers who made every visit feel like the most important day of the week — patient, generous, deeply present. Watching them change made me want to understand why. And then it made me want to do something about it.</p>
<div class="pullquote">
<p>I don't know yet whether I'll go into research, medicine, bioengineering, or something that doesn't have a name yet. But I know the problem I want to work on for the rest of my life.</p>
</div>
<p class="story-body">NeuroLens is where I build toward that. It's a research journal, a learning log, and a long-term commitment made public. Every entry represents something I genuinely tried to understand — not something I skimmed. The best way I know to honor what my grandfathers gave me is to build something that might, one day, give something back.</p>
<div class="about-grid">
<div class="about-card"><div class="about-card-label">School</div><div class="about-card-val">Mercersburg Academy, Pennsylvania · Boarding student</div></div>
<div class="about-card"><div class="about-card-label">From</div><div class="about-card-val">South Korea · Class of 2028</div></div>
<div class="about-card"><div class="about-card-label">Currently exploring</div><div class="about-card-val">Deep brain stimulation, CRISPR, anti-amyloid therapies, AR neuroscience, brain mapping</div></div>
<div class="about-card"><div class="about-card-label">Long-term goal</div><div class="about-card-val">Contribute to curing Parkinson's and Alzheimer's — through research, biotech, or both</div></div>
<div class="about-card"><div class="about-card-label">This site is</div><div class="about-card-val">A living journal of learning — not a finished product. Updated as I go.</div></div>
<div class="about-card"><div class="about-card-label">Personal</div><div class="about-card-val">Two grandfathers. Two diagnoses. One reason to keep reading past midnight.</div></div>
</div>
</div>
</section>
<div class="container">
<footer>
<div class="footer-name">NeuroLens · Mercersburg Academy · Class of 2028</div>
<div class="footer-links">
<a href="#story">Story</a>
<a href="#topics">Topics</a>
<a href="journal.html">Journal</a>
<a href="#about">About</a>
</div>
</footer>
</div>
</body>
</html>